Categoria: Profissionais

MacCallum CA, Russo EB. Practical considerations in medical cannabis administration and dosing. Eur J Intern Med. 2018 Mar;49: 12-9. Barnes M, Barnes J. Cannabis: the evidence for medical use. London: All-Party Parliamentary Group for Drug Policy Reform. May 2016. Wilkinson ST, Radhakrishnan R, D’Souza DC. Impact of cannabis use on the development of psychotic disorders.

MacCallum CA, Russo EB. Practical considerations in medical cannabis administration and dosing. Eur J Intern Med. 2018 Mar;49: 12-9. Häuser W, Finn DP, Kalso E, et al. European Pain Federation (EFIC) position paper on appropriate use of cannabis-based medicines and medical cannabis for chronic pain management. Eur J Pain. 2018 Oct;22(9): 1547-64. Grotenhermen F. Pharmacokinetics

Health Canada. Information for Health Care Professionals: Cannabis and the cannabinoids. October 2018. ISBN: 978-0-660-27828-5. Pertwee RG. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta 9-tetrahydrocannabivarin. Br J Pharmacol. 2008 Jan;153(2):199-215. Lucas P, Walsh Z. Medical cannabis access, use, and substitution for prescription opioids and other substances: A

(GENERAL) 1. US National Library of Medicine. ClinicalTrials.gov: Cannabis studies. Accessed September 1, 2021: https://clinicaltrials.gov/ct2/results?cond=&term=Cannabis&cntry=&state=&city=&dist= (PAIN) 2. Di Marzo V, Piscitelli F. The endocannabinoid system and its modulation by phytocannabinoids. Neurotherapeutics. 2015 Oct;12(4): 692-8. 3. Woodhams SG, Chapman V, Finn DP, Hohmann AG, Neugebauer V. The cannabinoid system and pain. Neuropharmacology. 2017 Sep; 124: 105-120.

European Medicines Agency. Guideline on good agriculture and collection practice for starting materials of herbal origin. EMEA/HMPC/246816/2005. Accessed February 15, 2021: https://www.ema.europa.eu/en/good-agricultural-collection-practice-starting-materials-herbal-origin

Hand A, Blake A, Kerrigan P, Samuel P, Friedberg J. History of medical cannabis. J Pain Manage 2016; 9: 387–94. World Health Organization. UN Commission on Narcotic Drugs reclassifies cannabis to recognize its therapeutic uses. News release. December 4, 2020. Accessed November 8, 2021. https://www.who.int/news/item/04-12-2020-un-commission-on-narcotic-drugs-reclassifies-cannabis-to-recognize-its-therapeutic-uses PubMed: Cannabis search results. Accessed November 8, 2021: https://pubmed.ncbi.nlm.nih.gov/?term=Cannabis&timeline=expanded